Identifying patients sensitive to anthracycline-containing therapy with quantitative proteomic and genomic profiling

Schwartz, S; Cecchi, F; Tian, Y; Yau, C; Szeto, C; Rubner, M; Erber, R; Beckmann, MW; Hartmann, A; Benz, S; Hembrough, T; Fasching, P

CANCER RESEARCH, 2018; 78 (4):